Pathologic assessment after neoadjuvant chemotherapy for non-small cell lung cancer: Importance and implications of distinguishing adenocarcinoma from squamous cell carcinoma

PURPOSE: Major pathologic response (MPR) following neoadjuvant chemotherapy (NAC) for non-small cell lung cancer (NSCLC) has been defined as ≤10% residual viable tumor, without distinguishing between histologic types. We sought to investigate whether the optimal cutoff percentage of residual viable...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Thorac Oncol
Main Authors: Qu, Yang, Emoto, Katsura, Eguchi, Takashi, Aly, Rania G., Zheng, Hua, Chaft, Jamie E., Tan, Kay See, Jones, David R., Kris, Mark G., Adusumilli, Prasad S., Travis, William D.
Format: Artigo
Sprog:Inglês
Udgivet: 2018
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6382593/
https://ncbi.nlm.nih.gov/pubmed/30503889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2018.11.017
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker